Your prediction
ALS Ltd Stock
Heavy losses for ALS Ltd today as the stock fell by -€0.900 (-6.290%).
Pros and Cons of ALS Ltd in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of ALS Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| ALS Ltd | -6.290% | 6.349% | -1.471% | 34.000% | 8.065% | 76.316% | 98.519% |
| Seek Ltd | 1.790% | 0.000% | -6.044% | -28.151% | -34.733% | -41.034% | -55.699% |
| Downer EDI Ltd | -3.350% | 5.479% | -2.941% | 38.323% | 4.054% | 108.108% | 29.775% |
| Fti Consulting | 0.740% | -8.108% | -12.258% | -8.108% | -6.849% | -15.000% | 15.254% |
News
Dutch Bros Q1 Earnings Call Highlights
Dutch Bros (NYSE:BROS) reported stronger-than-expected first-quarter results and raised its full-year outlook
North American Niobium Highlights 0.150% Nb2O5 with 124.53 ppm Dy2O3 from Pegmatite Grab Sample and 0.19% TREO from REE-Bearing Carbonatite Outcrop at Seigneurie, Québec
Vancouver, British Columbia – February 17, 2026 – North American Niobium and Critical Minerals Corp. (CSE: NIOB) (OTCQB: NIOMF) (FSE: KS82.F) (“North American Niobium” or the “Company”) is
UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor Neuron Diseases, including ALS, and Breakthrough Therapeutic and Diagnostic Opportunities
- This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo in ALS patients, which is carried to the CNS, where it binds to and damages